ProKidney Corp. (PROK) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
ProKidney Corp. (PROK) Earnings Overview
As of June 23, 2026, ProKidney Corp. (PROK) reported trailing twelve-month net income of -$75M, reflecting +16.1% year-over-year growth. The company earned $-0.53 per diluted share over the past four quarters, with a net profit margin of -7725.2%.
Looking at the long-term picture, PROK's historical earnings data spans multiple years. The company achieved its highest annual net income of -$27M in fiscal 2020.
ProKidney Corp. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RCKT (-$209M net income), FATE (-$130M net income, -2051.1% margin), NTLA (-$395M net income, -609.9% margin), PROK has comparable earnings metrics. Compare PROK vs RCKT →
PROK Earnings vs Peers
Earnings metrics vs comparable public companies
PROK Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$69M | -12.7% | -$165M | $-0.52 | -7725.2% | -18477.8% |
| 2024 | -$61M | -72.5% | -$184M | $-0.62 | -80507.9% | -241678.9% |
| 2023 | -$35M | +67.2% | -$152M | $-0.57 | - | - |
| 2022 | -$108M | -95.9% | -$153M | $-1.76 | - | - |
| 2021 | -$55M | -106.2% | -$55M | $-1.73 | - | - |
| 2020 | -$27M | +66.4% | -$27M | $-0.14 | - | - |
| 2019 | -$80M | - | -$79M | $-1.01 | - | - |
Download Data
Export PROK earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PROK — Frequently Asked Questions
Quick answers to the most common questions about buying PROK stock.
What is PROK earnings per share (EPS)?
PROK trailing twelve-month (TTM) diluted EPS is $-0.53, reflecting +16.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is ProKidney Corp.'s net income?
ProKidney Corp. (PROK) trailing twelve-month net income is $-75M as of 2025. Earnings grew +16.1% year-over-year.
Is PROK profitable?
PROK is not currently profitable on a TTM basis, reporting a net loss of $-75M. Net margin is -7725.2%. Investors should monitor for a return to profitability.
What is PROK's earnings growth rate?
PROK compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are PROK's profit margins?
ProKidney Corp. net profit margin is -7725.2%, operating margin is -18477.8%, and gross margin is +100.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -19.6%.
Is PROK growing earnings?
Yes, PROK earnings are accelerating — EPS growth of +16.1% exceeds the 5-year CAGR of N/A. TTM net income reached $-75M. Earnings momentum is strengthening.
What was PROK's best earnings year?
ProKidney Corp.'s highest annual net income on record is $-27M, achieved in fiscal year 2020. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were PROK's earnings last quarter?
PROK's most recent reported quarter was Q1 2026. Net income was $-23M with diluted EPS of $-0.16. For a full breakdown of all quarters, see the quarterly earnings table on this page.